Search Results 821-830 of 8280 for 谷歌搜索引擎留痕咨询邮箱:lgooxc@hotmail.com
The purpose of this study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to approximately 51 months ...
Gemcitabine hydrochloride may prevent tumor cells from multiplying by damaging their deoxyribonucleic acid (DNA) molecules that contain instructions for the ...
The purpose of this study is to assess the effects of Peptamen Intense on body weight in tube-fed adults with obesity. Participation eligibility. Participant ...
The purpose of this study is to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Intrathecally Administered ALN-APP in Patients with ...
About this study. RATIONALE: Drugs used in chemotherapy, such as bendamustine hydrochloride, work in different ways to stop the growth of cancer cells, ...
Vande Voort, Jennifer L. M.D. ... Vasquez, Adriana R. M.D. ... Veldic, Marin M.D. ... Vickers, Kristin S. Ph.D., L.P.. vickers.kristin@mayo.edu; Professor of ...
About this study · To evaluate the pharmacogenomic profile (PGx) by genotyping 22 genes, including the CYP2D6 genotype, in patients with functional GI disorders.
The purpose of this study is to create a registry that follows patients for a total of 5 years from the date of the first liver ablation procedure with the ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This study will evaluate the long term efficacy, safety, and tolerability of repeated administration of adalimumab in subjects with Crohn's disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.